维普中文期刊产品整合服务
38篇 您的检索式:作者名="Sanoff"
    题名 作者 年代 出处 被引量
1Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741 显示文摘SANOFF HK SARGENT DJ CAMPBELL ME 2008J Clin Oncol2008,26,35:1
2Defining the toxicology of aging显示文摘Sorrentino J A Sanoff H K Sharpless N E 2014Trends in Mol Med2014,20,:1
3Colon cancer in older a- dults显示文摘Raftery L Sanoff H K Goldberg R 2008SeminOncol2008,35,6:1
4A quantitative model for age - dependent expression of the P16INK4a tumor suppressor 显示文摘Tsygankov D Liu Y Sanoff HK 2009Proc Natl Acad Sci USA2009,106,16:1
5A system- atic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients 显示文摘Sanoff HK Goldberg RM Pignone MP 2007Clin Colorectal Cancer2007,6,10:1
6Managing older patients with colorectal cancer 显示文摘Sanoff HK Bleiberg H 2007J Clin Oncol2007,25,14:1
7Five year data and prognostic factor analysis of oxaliplatin and irinoteean combinations for advanced colorectal cancer: N9741 显示文摘Sanoff H K Sargent D J Campbell M E 2008J Clin Oncol2008,26,35:1
8INK4/ARF transcript ex- pression is associated with chromosome 9p21 variants linked to atherosclerosis 显示文摘Liu Y Sanoff H K Cho H 2009PLoS One2009,4,4:1
9Defining the toxicology of aging 显示文摘Sorrentino JA Sanoff HK Sharpless NE 2014Trends Mol Med2014,20,7:1
10Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer:N9741显示文摘SANOFF H K SARGENT D J CAMPBELL M E 2008J Clin Oncol2008,26,35:1
11INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atheroselerosis 显示文摘Liu Y Sanoff HK Cho H 2009Plos One2009,4,4:1
12Comparison of adverse event s during 5-f luorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage coloncancer:a populat ion-based analysis显示文摘Sanoff HK Carpenter WR Freburger J 2012Cancer2012,118,17:1
13INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis显示文摘Liu Y Sanoff HK Cho H 2009PLoS One2009,4,:1
14Phase I1 study of capecitabine, oxaliplatin, and cetuximab for ad- vanced hepatocellular carcinoma显示文摘Sanoff H K Bernard S Goldberg R M 2011Gastrointest Cancer Res2011,4,3:1
15Phase II Study of Capecitabine,Oxaliplatin,and Cetuximab for Advanced Hepatocellular Carcinoma显示文摘Sanoff HK Bernard S Goldberg RM 2011Gastrointest Cancer Res2011,4,3:1
16Phase II study of capecitabine, oxaliplatin, and cetuximab for advanced hepatoceUular carcinoma显示文摘Sanoff HK Bernard S Goldberg RM 2011Gastrointest Cancer Res2011,4,3:1
17Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer显示文摘Sanoff HK Carpenter WR Martin CF 0,,:1
18Five-year data and prog-nostic factor analysis of oxaliplatin and irinotecan combinations for ad-vanced colorectal cancer:N9741显示文摘Sanoff HK Sargent DJ Campbell ME 0,,:1
19Phase II Study of Capecitabine,Oxaliplatin,and Cetuximab for Advanced Hepatocellular Carcinoma显示文摘Sanoff HK Bernard S Goldberg RM 0,,03:1
20Impact of acute kidney injury on chronic kidney disease and its progression显示文摘Sanoff S Okusa MD 0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费